Skip to main content

Conflict of Interest and Medical Innovation Ensuring Integrity While Facilitating Innovation in Medical Research: Workshop Summary (2014) / Chapter Skim
Currently Skimming:

References
Pages 49-52

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 49...
... 2011. Responsibility of applicants for promoting objectivity in research for which Public Health Service funding is sought and responsible prospective contractors; final rule.
Read the entire page →
From page 50...
... 2012. Harmonizing reporting on potential conflicts of interest: A common disclosure process for health care and life sciences, Discussion Paper, Institute of Medicine, Washington, DC.
Read the entire page →
From page 51...
... 2012. Glaxo agrees to pay $3 billion in fraud settlement.
Read the entire page →

Key Terms

  • workshop summary
  • panelists conflicted
  • fraudulent price
  • responsible prospective
  • promoting objectivity

  • prospective contractors
  • discussion paper
  • medical centers
  • health industry
  • settle suit

  • development costs
  • resident duty
  • potential conflicts
  • policy proposal
  • industry practices

  • enhancing sleep
  • reviews drug
  • nature reviews
  • service funding
  • access project

  • mention risks
  • disclosure process
  • drug development
  • trial suspended
  • data access

  • sheets fail
  • academic medical
  • create conflicts
  • resolve claims
  • harmonizing reporting


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.